Transfected human dendritic cells as cancer vaccines

Nature Biotechnology

Volumn 16, Issue 4, 1998, Pages 335-336

  Liu, Margaret ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; DNA; RNA;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; PLASMID;

CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELLS; DNA; HUMANS; PLASMIDS; RNA; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0032044455     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0498-335     Document Type: Article

References (7)

1. Boczkowski, D. et al. 1996. J. Exp. Med. 184:465-472.
2. Nair, S.K. et al. 1998. Nature Biotechnology 16:364-369.
3. Macatonia, W.E., Patterson, S., and Knight, S.C. 1991. Immunology 74:399-406.
4. Nestle, F.O. et al. 1998. Nat. Med. 4:328-332.
5. Huang, A.Y.C. et al. 1994. Science 264:961-965.
6. Albert, M.L., Sauter, B., and Bhardwaj, N. 1998. Nature 392:86-89.
7. Donnelly J.J. et al. 1997. Annu. Rev. Immunol. 15:617-648.